| Code | Description | Claims | Beneficiaries | Total Paid |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
1,781 |
1,363 |
$206K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
3,199 |
2,737 |
$114K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
2,213 |
1,652 |
$77K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
880 |
719 |
$8K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
99 |
97 |
$4K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
4,096 |
3,243 |
$2K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
134 |
126 |
$998.41 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
2,729 |
2,271 |
$984.59 |
| U0001 |
Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel |
34 |
34 |
$718.20 |
| 99000 |
|
2,006 |
1,578 |
$4.01 |
| 99051 |
|
28 |
28 |
$0.00 |